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ABSTRACT Poliovirus RNA stimulates incorporation of
35S from both [35Smethionine and formyl{35S]methionyl-
tRNAfmet in cell-free systems derived from HeLa cells or
from poliovirus-infected HeLa cells. The largest product
formed under the direction of the viral RNA is the same size
as the polyprotein thought to represent translation of the en-
tire RNA. Synthesis of this polyprotein and other large prod-
ucts was stimulated greatly by increasing the salt concentra-
tion during the reaction from the optimum for initiation (90
mM) to the optimum for elongation (155 mM). Only one initi-
ation peptide could be identified, and a tryptic digest of the
product contained mainly peptides that cochromatographed
with peptides from authentic viral proteins. The RNA from a
deletion mutant of poliovirus initiated protein synthesis at
the same site used by standard RNA and programmed syn-
thesis of an appropriately deleted set of polypeptides. The re-
sults strongly support the model of translation of poliovirus
RNA from a single initiation site into a continuous polypro-
tein that is cleaved to form the functional proteins. It is sug-
gested that uninfected HeLa cell extracts can carry out the
cleavages of nascent polyprotein.
The only viral messenger RNA found in poliovirus-infected
cells is the 35S viral RNA (1, 2). Analysis of viral protein syn-
thesis in infected cells has led to the hypothesis that the 35S
RNA of poliovirus and other picornaviruses is translated
from a single site near the 5'-end of the RNA into one con-
tinuous polypeptide (3). All the functional viral proteins
would then be proteolytic cleavage products from this single
polypeptide. The strongest evidence for this hypothesis is 2-
fold: (i) the identification, in cells that were treated to inhib-
it proteolysis, of a virus-specific polypeptide that is larger
than 200,000 daltons and could be the complete genome
transcript (3) and (ii) the ability to map the viral genome
using inhibitors of initiation of protein synthesis, a form of
analysis which depends on the existence of only a single ini-
tiation site (4-6). The proteolytic cleavages responsible for
synthesis of the viral proteins are of two forms, cleavages of
nascent protein that occur soon after a given peptide bond
has been formed and cleavages which have much longer
half-times of occurrence (3, 5).
To test the hypothesis of a single initiation site for protein
synthesis on a picornavirus messenger RNA requires analysis
of cell-free protein synthesis programmed by the RNA. Pol-
iovirus RNA has not been previously studied as a messenger
RNA in eukaryotic cell-free systems, but RNA from another
picornavirus, encephalomyocarditis (EMC) virus has been
used successfully. In vitro, RNA of EMC virus is apparently
translated from a single initiation site (7, 8) to generate a
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spectrum of polypeptides which appear to result from pre-
mature termination rather than from proteolytic cleavage
(9-11). In most cases, only 60% of the EMC viral genome is
expressed in vitro; however, complete translation of RNA of
EMC virus in a cell-free system prepared from EMC virus-
infected L cells occurs at a very low frequency (12).
MATERIALS AND METHODS
Virus Production. Poliovirus Mahoney Type I was grown
in HeLa cells as described (15) except that virus was ad-
sorbed to the cells for 30 min at 00. Preparations of polio-
virus defective interfering DI(1) were kind gifts of Dr.
Charles Cole and Dr. Martinez Hewlett.
Preparation of Viral RNA. RNA was prepared from puri-
fied virions by the sodium dodecyl sulfate (NaDodSO4)/ace-
tic acid extraction method described (16, 17). The RNA was
precipitated with ethanol, washed twice with ethanol, resus-
pended in water at a concentration of 250-500 ,ug/ml, and
stored in small aliquots at -900. Labeled RNA was prepared
from purified virions, the RNA of which had been labeled
with 10 MCi/ml of [3H]uridine (New England Nuclear) from
30 min to 6 hr after infection.
Preparation of Poliovirus Proteins. HeLa cells infected
in the presence of actinomycin D were harvested 3 hr after
infection and resuspended in Earle's saline containing 12
.uCi/ml of [a5S]methionine or 50 ACi/ml of [14C]arginine.
The large molecular weight precursors to the virus proteins
were prepared by labeling the infected cells in the presence
of amino acid analogs, fluorophenylalanine, canavanine,
ethionine, and 2-azetidine carboxylic acid, as described by
Jacobson, Asso, and Baltimore (3). Actinomycin D was the
kind gift of Merck, Sharp and Dohme.
Preparation of Cell-Free Extracts. Extracts from HeLa
cells were prepared as described (18, 19) except that cells
were disrupted in a Dounce homogenizer in extract buffer
[20 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic
acid (Hepes), pH 7.5; 120 mM KCI, 6 mM 2-mercaptoetha-
nol; 5 mM MgOAc2] without being preswollen in hypotonic
buffer (18). Infected cell extracts were prepared from HeLa
cells infected with poliovirus at a multiplicity of infection of
100 and harvested 2 hr after infection.
Cell-Free Protein Synthesis. Conditions for cell-free pro-
tein synthesis in preincubated HeLa extracts were as de-
scribed by McDowell et al. (18) with the following modifi-
cations: the concentration of magnesium acetate varied from
2.0 to 3.0 mM; the concentration of creatine phosphokinase
was 0.1 mg/ml; in some cases, the reaction mixture was in-
cubated for 15 min with 92 or 112 mM KCl, then the KCI
concentration was increased to 155 mM and the mixture in-
cubated an additional 105 min. All reactions were at 300.
Polyacrylamide Gel Electrophoresis. Cell-free reactions
4158 Microbiology: Villa-Komaroff et al.
Table 1. Incorporation of [ 3I S ] methionine and
formyl- [ I"S I methionine (from f [3'S ] Met-tRNAfMet)




Source of S-30 + RNA - RNA + RNA - RNA
Mock infected (a ) 8,876 4,146 494 71
HeLa cells (b) 137,310 25,200 22,730 1,770*
Infected (a) ND ND 481 97
HeLacells (b) 265,860 36,590 4,860 1,270t
Reaction mixtures (50 gl) containing poliovirus RNA and 250
.UCi/ml of [35S]methionine or f[35S]Met-tRNAfMet were incubated
under optimal standard conditions for 50 min. Radioactivity incor-
porated in the reaction was determined by terminating the reaction
with 0.1 M NaOH and incubating at 370 for 15 min. The products
of the reaction were then precipitated with trichloroacetic acid; the
precipitate was collected on ground glass filters and dried. Radio-
activity was determined in a liquid scintillation counter in a toluene
1,4-bis[2(5-phenyloxazolyl)]benzene (POPOP) scintillant. HeLa
cell extracts designated (a) were resuspended in hypertonic buffer
for 10 min before being disrupted. Extracts designated (b) were
disrupted immediately as described in Materials and Methods.
ND = not done.
* Salt concentration was increased after 15 min. Mixture was in-
cubated for 120 min.
t Mixture was incubated for 120 min.
were terminated by adding pancreatic ribonuclease to 100
,ug/ml and incubating the mixture at 370 for 30 min. The
products of the reaction were then precipitated with 10 vol-
umes of acetone and analyzed on polyacrylamide slab gels
containing NaDodSO4 (20). The gels were fixed in 10% ace-
tic acid, 25% propanol, stained with Coomassie Blue, dried,
and autoradiographed.
Preparation of f[3sSIMet-tRNAfMet. A preparation of
tRNA from yeast containing about 33% tRNAfMet and no de-
tectable tRNAMet was the kind gift of Dr. Uttam RajBhand-
ary. The tRNAfMet was charged with -5Smethionine and
formylated with an E. coli S100 as described (21).
RESULTS
Characteristics of cell-free protein synthesis
To determine the ability of poliovirus RNA to direct protein
synthesis in preincubated extracts of mock-infected or polio-
virus-infected HeLa cells, either [35S]methionine or formyl-
[35S]methionyl-tRNAfMet was used as precursor. The latter
precursor selectively measures initiation of protein synthesis
because NH2-terminal formyl-methionyl residues are not
cleaved from protein but NH2-terminal [a5S]methionine is
rapidly cleaved off (21). Table 1 shows that incorporation of
both precursors was stimulated markedly but to variable ex-
tents by addition of 35S poliovirus RNA to either uninfected
cell or infected cell extracts. Much more activity was evident
if the extracts were made without a hypotonic swelling peri-
od for the cells.
The optimum conditions for synthesis were studied using
[35S]methionine as precursor. Because each extract had dif-
ferent characteristics, even when made and tested under ap-
parently identical conditions, we optimized the Mg++ con-
centration for each extract preparation. The optimal Mg++
concentration varied from 2.0 to 3.0 mM. A broad KC1 opti-
mum from 92 to 112 mM was found. Incorporation in-
creased with increasing poliovirus RNA concentration up to
30-60 jtg of RNA per ml. The amount of RNA needed to
saturate the reaction was determined for each extract since
excess RNA inhibited synthesis. Addition of tRNA, hemin,
or a reticulocyte ribosome salt wash did not enhance transla-
tion of poliovirus RNA in these preincubated extracts. Once
optimal conditions had been determined, frozen aliquots of
a given preparation maintained their characteristics for at
least 6 months.
Protein synthesis in vitro under salt shift conditions
To study the size of the polypeptides synthesized under the
direction of viral RNA, the products were separated by elec-
trophoresis through a slab gel of polyacrylamide which was
analyzed by autoradiography (Fig. 1). For comparison three
marker preparations were analyzed in parallel: virion pro-
teins (Fig. 1, lane 0); the total proteins made in infected
cells (lane P) and the polypeptides made in amino-acid ana-
log-treated infected cells (lane Q). The polypeptide marked
NCVP (noncapsid viral protein) 00 is the largest one found
in amino-acid analog-treated cells and is thought to corre-
spond to a translation product of the whole poliovirus ge-
nome (3). Polypeptides Oa and Ob derive from single cleava-
ges of the nascent NCVP 00 (13). NCVP 1 is the capsid pro-
tein precursor and is encoded by the 5'-end of the RNA (4,
6).
Two conditions were used from amino acid incorporation
in extracts incubated for 120 min. Either the K+ concentra-
tion was maintained at the optimum for incorporation (92
mM in this extract) or it was shifted to 155 mM after 15 min
of incubation. The salt shift was used because Mathews and
Osborn (22) had found that the rate of polypeptide elonga-
tion in mouse ascites cell extracts was increased by the high-
er K+ concentrations, but these concentrations inhibit initia-
tion too severely to be used from the outset of incubation. In
extracts incubated at a constant K+ concentration for 120
min a small amount of polypeptide of exactly the size of
NCVP 00 was evident (Fig. 1, lane M). It is not found until
120 min of incubation; at 60 and 90 min some NCVP Oa-
and much NCVP 1 was present (lanes K and L), while at 40
min some lower molecular weight polypeptides predomi-
nate.
When the salt shift was used, more of the largest polypep-
tides was evident. Lanes A-D of Fig. 1 show the products
made by infected cell extracts incubated 40, 60, 90, and 120
min, respectively; lane E shows the product of an uninfected
cell extract lacking added RNA; Lanes F-I show the prod-
ucts of uninfected cell extracts incubated 40, 60, 90, and 120
min, respectively, and lane N shows the products of an unin-
fected extract incubated 120 min in the absence of added
RNA. It is evident that the added poliovirus RNA caused
formation of a spectrum of polypeptides very similar to
those made in infected cells treated with amino acid analogs.
Proteins comigrating with NCVP 00, NCVP 0, NCVP 1,
NCVP 1 %, NCVP 2, NCVP 3b, and NCVP 4 are evident
among the products of these cell-free systems. In the infect-
ed cell, all of the polypeptides smaller than NCVP 00 are
thought to be generated by proteolysis.
Initiation of protein synthesis
Initiation of poliovirus protein synthesis appears to occur at
only one site in virus-infected cells (3, 24). To obtain an esti-
mate of the number of independent initiation sites on polio-
Proc. Nat. Acad. Sci. USA 72 (1975)
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FIG. 1. NaDodSO4/polyacrylamide gel electrophoresis of polypeptides synthesized in response to poliovirus RNA. Reaction mixtures (50
Al) containing either infected or mock-infected HeLa cell S-30, 250 gCi/ml of [35S]methionine, and poliovirus RNA were either incubated for
15 min with 92 mM KCl, then for an additional 105 min with 155 mM KCl (gels A-I) or were incubated for 120 min with 92 mM KCl (reac-
tions J-N). At the indicated times, 10-IAl aliquots were withdrawn from the reaction and prepared and analyzed as described in Materials
and Methods. NCVP, noncapsid viral protein; VP, viral protein. (A-D) Polypeptides synthesized in response to poliovirus RNA in an infect-
ed HeLa cell extract at 40, 60, 90, and 120 min, respectively. (E) Polypeptides synthesized in the absence of added RNA with a salt shift in
an infected cell extract after 120 min of reaction. (F-I) Polypeptides synthesized in a mock-infected HeLa cell extract after 40, 60, 90, and
120 min, respectively. (J-M) Polypeptides synthesized in a mock-infected HeLa cell extract with a constant KCl concentration of 92 mM
after 40, 60, 90, and 120 min of reaction, respectively. (N) Polypeptides synthesized in the absence of added RNA with a salt shift in a mock-
infected cell extract after 120 min of reaction. (0) [35S]Methionine-labeled proteins from purified virions. (P) [35S]Methionine-labeled virus-
specific proteins present in infected cells. (Q) Poliovirus proteins synthesized in the presence of amino-acid analogs as described in Materi-
als and Methods.
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FIG. 2. Tryptic digest of protein labeled with f[35S]Met-
tRNAfMet and synthesized in vitro under the direction of polio-
virus RNA and DI RNA. Reaction mixtures (100 Ml) containing
f[35S]methionine-tRNAfMet, unlabeled methionine, and 50 gg/ml
of poliovirus RNA (-), or an unknown amount of DI-RNA (---),
or no RNA (-* - *) were incubated 60 min with a constant K+ con-
centration of 112 mM. Products of the reaction were precipitated
and digested with trypsin as described in Materials and Methods.
The tryptic digests were subjected to ionophoresis at pH 3.5 as de-
scribed (26). The paper was dried and used to expose Kodak RP
Royal film for 3 days. The autoradiogram was scanned with a
Joyce Loebl microdensitometer under conditions where full-scale
pen deflection represented 1.49 A units.
virus RNA in vitro, the product directed by poliovirus RNA
was labeled with f[s5S] Met-tRNAfMet, digested with trypsin,
and analyzed by ionophoresis at pH 3.5. Only one f[s5S] me-
thionine-containing tryptic peptide was found in the prod-
uct synthesized in reactions using HeLa cell extracts (Fig. 2)
or ascites cell extracts (not shown). As measured by its elu-
tion position on a Bio-Gel P-2 column, this peptide had a
molecular weight of about 900 (data not shown).
The limited amount of radioactivity that could be incor-
porated from f[35S] Met-tRNAfMet made identification of the
size of all products retaining the NH2-terminal label diffi-
cult. We could, however, show that a protein migrating with
NCVP 1 was labeled in vitro by f [asS] Met-tRNAfMet, and
therefore it must contain the NH2-terminal peptide shown
in Fig. 2.
Tryptic peptide analysis of the product synthesized in
response to poliovirus RNA.
To determine if the polypeptides synthesized in vitro in re-
sponse to poliovirus RNA represented virus-specific pep-
tides, we compared a tryptic digest of the in vitro product
synthesized under salt shift conditions to a tryptic digest of
in vivo poliovirus-specific proteins (Fig. 3). Extensive over-
Microbiology: Villa-Komaroff et al.
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FIG. 3. Tryptic digest of [3H]arginine-labeled peptides synthe-
sized in vitro in the presence (A) or absence (B) of added polio-
virus RNA. A cell-free reaction mixture (300 Ml) incubated with a
salt shift was terminated after 120 min by incubation with ribonu-
clease, as described in Materials and Methods. The product was
precipitated with acetone and resuspended in 2% NaDodSO4, 0.1
M ammonium bicarbonate, and 1% 2-mercaptoethanol. The sam-
ple was boiled for 5 min, and glycerol was added to a concentration
of 20%. The polypeptides were layered onto a Sephadex G-150 col-
umn (25 cm X 1 cm) and eluted with 0.2% NaDodSO4, 0.1 M am-
monium bicarbonate. Fractions were collected by drops, and the
radioactivity of 10-Ml aliquots was determined to determine the
location of the labeled polypeptides. The polypeptides chromato-
graphed behind the void volume in a wide major peak. The frac-
tions of labeled polypeptides representing the larger cell-free prod-
ucts were pooled. In vivo viral proteins that had been prepared as
described in Materials and Methods were made 2% in NaDodSO4,
0.1 M in ammonium bicarbonate, and 1% in 2-mercaptoethanol
and boiled for 5 min. The in vivo and in vitro proteins were then
precipitated together with 10% trichloroacetic acid. The precipi-
tate was washed twice with 5% trichloroacetic acid, lyophilized re-
peatedly to remove residual acid, resuspended in 1% ammonium
bicarbonate, and digested for 12 hr at 379 with 50 ug of TPCK-
trypsin (Worthington Biochem.). Fresh trypsin (50 Mug) was added
and the sample digested an additional 4 hr. After lyophilization,
the digest was resuspended in 0.2 M pyridine titrated to pH 3.1
with glacial acetic acid and analyzed on a column of Technicon
type P chromobeads as described by Jacobson et al. (3). Fractions
were added to 10 ml of Aquasol (New England Nuclear) or 10 ml of
Handifluor (Mallinckrodt), and radioactivity was determined in a
liquid scintillation counter.
lap of the two patterns was evident. The in vitro derived
peptides that did not correspond to virus peptides appeared
to be derived from polypeptides synthesized by the residual
endogenous HeLa mRNA (Fig. 3B).
Translation of RNA from DI poliovirus particles
To test the notion that the polypeptides directed by polio-
virus RNA in the cell-free system are identical to their ap-
parent in vivo counterparts, we used the RNA from a mu-
tant of poliovirus [poliovirus DI(1)] known to lack about one-
third of the RNA encoding NCVP 1. In DI-infected cells,
NCVP 1 and all of the precursors that contain it are about
30,000 daltons shorter than their normal counterparts (13).
Therefore, translation of DI RNA in vitro should lead to ap-
propriately deleted products if the in vitro system mimics
the in vivo situation.
The products directed by DI RNA were compared with
products directed by standard RNA (Fig. 4). The results con-
firm the fidelity of the system: no NCVP 00 was directed by
DI RNA but a product (DI-NCVP 00) 12% shorter was
formed; no NCVP Oa was made but the appropriately delet-
ed form was found (DI-NCVP Oa); very little NCVP 1 was
evident but the deleted form, which comigrates with NCVP
3, was formed [DI(P)]. Synthesis of NCVP 1½k, NCVP 4, and
0
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FIG. 4. NaDodSO4polyacrylamide gel electrophoresis of poly-
peptides synthesized in response to standard and DI RNA. Reac-
tion mixtures (50 Ml) containing infected HeLa cell S-30, 250 MACi/
ml of [35S]methionine, and either poliovirus RNA --- -) or DI RNA
(-) were incubated with a salt shift as described in the legend to
Figure 1. After 120 min of incubation, 10 Ml of the mixture was pre-
pared and analyzed on NaDodSO4/polyacrylamide slab gel as de-
scribed in Materials and Methods. The dried gel was used to ex-
pose Kodak RP Royal x-ray film for 3 days. The autoradiogram
was scanned with a Joyce Loebl microdensitometer under condi-
tions where full-scale pen deflection represented 1.49 A units. The
arrows indicate the position on the same gel in parallel slots of
both standard and DI virus directed polypeptides synthesized in
vivo in the presence of amino acid analogs (3).
NCVP X was directed by both RNAs. These results are con-
sistent with the conclusion that faithful translation of stan-
dard and DI RNA occurs in vitro in extracts prepared from
HeLa cells and that some processing of the protein products
occurs.
To examine where on the DI RNA initiation of protein
synthesis occurred, a tryptic digest of f[a5S] methionine-la-
beled products was submitted to ionophoresis. A single la-
beled peptide was found which comigrated at pH 3.5 with
the initiation peptide formed under the direction of stan-
dard RNA (Fig. 2). The two peptides also comigrate at pH
1.9 (not shown). The apparent identity of initiation sites on
the two RNAs suggests that DI RNA contains a deletion in-
ternal to the site of initiation.
DISCUSSION
Previous study of poliovirus-infected cells generated the hy-
pothesis that the viral RNA is translated from a single initia-
tion site into a single continuous chain of amino acids that is
cleaved to form the functional proteins. The present analysis
of protein synthesis in vitro directed by poliovirus RNA sup-
ports the hypothesis: the product is virus-specific by tryptic
peptide analysis; only a single initiation site on the RNA was
found; a product thought to be the translation product of the
entire genome could be identified, and discrete products
that comigrate with authentic viral proteins were evident.
The nature of the products was verified by studying the
translation of the RNA from a deletion mutant of poliovirus.
The incorporation of f[a5S] Met-tRNAfMet into a single
tryptic peptide (Fig. 2) indicates that initiation of protein
synthesis in vitro occurs at only one site on the added polio-
virus or DI RNA. Although there is no direct evidence that
this site is the authentic initiation site, it seems likely that
this is the case because of the correspondence in size of in
Proc. Nat. Acad. Sci. USA 72 (1975)
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vitro and in vivo products. Similar results (and a similar con-
clusion) have been obtained in studies utilizing RNA of
EMC virus (7-12).
In vivo, two classes of proteolytic cleavage of the polio-
virus RNA translation product can be distinguished: nascent
cleavages, which are rapid cleavages of the polypeptide
while it is still in the process of elongation, and cytoplasmic
cleavages, which occur more slowly and involve further pro-
cessing of the nascent cleavage products. No evidence for
cytoplasmic cleavages during cell-free synthesis has been
found. However, our results are consistent with the notion
that the HeLa cell-free system carries out the nascent clea-
vages with approximately 80% efficiency. This value is esti-
mated from the ratio of NCVP 00 to the lower molecular
weight products in Fig. 4. The evidence that the lower mo-
lecular weight products are formed by cleavage is as follows.
(i) The various products appear to correspond to in vivo pro-
teins both because of the exact correspondence of electro-
phoretic mobility and because these polypeptides containing
NCVP 1 are all appropriately shifted in the in vitro product
of DI RNA translation. (ii) The map of the poliovirus ge-
nome contains (5' - 3') NCVP 1 - NCVP X - NCVP 1I%(4). (iii) The products include proteins that comigrate with
not only NCVP 1, which could be formed by a premature
termination, but also with NCVP 1½ and NCVP X (see Fig.
4). Since it is difficult to envisage how these polypeptides,
formed by both wild-type and DI RNA, could arise by pre-
mature termination, we assume that they are formed by ei-
ther direct initiation or by proteolytic cleavage. (iv) Since
only one initiation site is evident, we believe that nascent
cleavages must be occurring.
The occurrence of nascent cleavages in extracts from un-
infected cells would imply that either host cell enzymes are
responsible or that the nascent polypeptides are proteases.
Because the nascent cleavages occur so rapidly, both NCVP
1 and NCVP X would have to be proteases; this is unlikely,
and we conclude that host cell enzymes carry out the cleav-
age. Our results differ from results obtained by others
studying the translation of EMC virus RNA. The synthesis of
a polypeptide larger than the capsid precursor in extracts
from uninfected cells in response to EMC virus RNA and a
polypeptide the same size as the capsid precursor in extracts
from EMC virus-infected cells has been reported for cell-
free systems derived from mouse L-cells and plasmacytoma
cells (12, 25). Both groups suggest that the proteolytic activi-
ty necessary to process EMC viral proteins is activated in in-
fected cells.
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